Thomas M. Enzler
Hematology | Oncology | Internal Medicine
1500 E Medical Center Dr
Floor B1 Reception E
Ann Arbor, MI 48109
Floor B1 Reception E
Ann Arbor, MI 48109
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Case Report: An exceptional response to a novel immunotherapy-based combination treatment for resected pancreatic ductal adenocarcinoma with recurrence to the abdominal wall.
Journal: Frontiers in oncology
Published: June 19, 2025
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 09, 2025
A phase 2 multicenter trial of rucaparib and nivolumab as maintenance therapy in patients with advanced biliary tract cancer: BilT-02.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 29, 2025
BilT03: Phase 1b/2 multicenter trial of nivolumab with 5-fluorouracil and liposomal irinotecan for previously treated advanced biliary tract cancer.
Journal: Med (New York, N.Y.)
Published: April 05, 2024
A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions.
Journal: International journal of molecular sciences
Published: January 27, 2024
A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 19, 2023
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 04, 2023
Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 11, 2023
Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma.
Journal: Oncoimmunology
Published: May 13, 2022
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 07, 2022
Emerging antibody therapies for pancreatic adenocarcinoma: a review of recent phase 2 trials.
Journal: Expert opinion on emerging drugs
Published: March 18, 2021
Last Updated: 09/26/2026